Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection

ABSTRACTActivin A strongly influences immune responses; yet, few studies have examined its role in infectious diseases. We measured serum activin A levels in two independent tuberculosis (TB) patient cohorts and in patients with pneumonia and sarcoidosis. Serum activin A levels were increased in TB...

Full description

Bibliographic Details
Main Authors: Natalie E. Nieuwenhuizen, Geraldine Nouailles, Jayne S. Sutherland, Joanna Zyla, Arja H. Pasternack, Jan Heyckendorf, Björn C. Frye, Kerstin Höhne, Ulrike Zedler, Silke Bandermann, Ulrike Abu Abed, Volker Brinkmann, Birgitt Gutbier, Martin Witzenrath, Norbert Suttorp, Gernot Zissel, Christoph Lange, Olli Ritvos, Stefan H. E. Kaufmann
Format: Article
Language:English
Published: American Society for Microbiology 2024-03-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.03408-23
_version_ 1797263247217262592
author Natalie E. Nieuwenhuizen
Geraldine Nouailles
Jayne S. Sutherland
Joanna Zyla
Arja H. Pasternack
Jan Heyckendorf
Björn C. Frye
Kerstin Höhne
Ulrike Zedler
Silke Bandermann
Ulrike Abu Abed
Volker Brinkmann
Birgitt Gutbier
Martin Witzenrath
Norbert Suttorp
Gernot Zissel
Christoph Lange
Olli Ritvos
Stefan H. E. Kaufmann
author_facet Natalie E. Nieuwenhuizen
Geraldine Nouailles
Jayne S. Sutherland
Joanna Zyla
Arja H. Pasternack
Jan Heyckendorf
Björn C. Frye
Kerstin Höhne
Ulrike Zedler
Silke Bandermann
Ulrike Abu Abed
Volker Brinkmann
Birgitt Gutbier
Martin Witzenrath
Norbert Suttorp
Gernot Zissel
Christoph Lange
Olli Ritvos
Stefan H. E. Kaufmann
author_sort Natalie E. Nieuwenhuizen
collection DOAJ
description ABSTRACTActivin A strongly influences immune responses; yet, few studies have examined its role in infectious diseases. We measured serum activin A levels in two independent tuberculosis (TB) patient cohorts and in patients with pneumonia and sarcoidosis. Serum activin A levels were increased in TB patients compared to healthy controls, including those with positive tuberculin skin tests, and paralleled severity of disease, assessed by X-ray scores. In pneumonia patients, serum activin A levels were also raised, but in sarcoidosis patients, levels were lower. To determine whether blockade of the activin A signaling axis could play a functional role in TB, we harnessed a soluble activin type IIB receptor fused to human IgG1 Fc, ActRIIB-Fc, as a ligand trap in a murine TB model. The administration of ActRIIB-Fc to Mycobacterium tuberculosis-infected mice resulted in decreased bacterial loads and increased numbers of CD4 effector T cells and tissue-resident memory T cells in the lung. Increased frequencies of tissue-resident memory T cells corresponded with downregulated T-bet expression in lung CD4 and CD8 T cells. Altogether, the results suggest a disease-exacerbating role of ActRIIB signaling pathways. Serum activin A may be useful as a biomarker for diagnostic triage of active TB or monitoring of anti-tuberculosis therapy.IMPORTANCETuberculosis remains the leading cause of death by a bacterial pathogen. The etiologic agent of tuberculosis, Mycobacterium tuberculosis, can remain dormant in the infected host for years before causing disease. Significant effort has been made to identify biomarkers that can discriminate between latently infected and actively diseased individuals. We found that serum levels of the cytokine activin A were associated with increased lung pathology and could discriminate between active tuberculosis and tuberculin skin-test-positive healthy controls. Activin A signals through the ActRIIB receptor, which can be blocked by administration of the ligand trap ActRIIB-Fc, a soluble activin type IIB receptor fused to human IgG1 Fc. In a murine model of tuberculosis, we found that ActRIIB-Fc treatment reduced mycobacterial loads. Strikingly, ActRIIB-Fc treatment significantly increased the number of tissue-resident memory T cells. These results suggest a role for ActRIIB signaling pathways in host responses to Mycobacterium tuberculosis and activin A as a biomarker of ongoing disease.
first_indexed 2024-04-25T00:09:58Z
format Article
id doaj.art-3d3667d5541a46edbd2bf30cc823eefc
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-04-25T00:09:58Z
publishDate 2024-03-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-3d3667d5541a46edbd2bf30cc823eefc2024-03-13T14:01:04ZengAmerican Society for MicrobiologymBio2150-75112024-03-0115310.1128/mbio.03408-23Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infectionNatalie E. Nieuwenhuizen0Geraldine Nouailles1Jayne S. Sutherland2Joanna Zyla3Arja H. Pasternack4Jan Heyckendorf5Björn C. Frye6Kerstin Höhne7Ulrike Zedler8Silke Bandermann9Ulrike Abu Abed10Volker Brinkmann11Birgitt Gutbier12Martin Witzenrath13Norbert Suttorp14Gernot Zissel15Christoph Lange16Olli Ritvos17Stefan H. E. Kaufmann18Department of Immunology, Max Planck Institute for Infection Biology, Chariteplatz, Berlin, GermanyDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyVaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The GambiaDepartment of Data Science and Engineering, Silesian University of Technology, Gliwice, PolandDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, FinlandDepartment of Medicine I, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Pneumology, Clinic, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Pneumology, Clinic, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Immunology, Max Planck Institute for Infection Biology, Chariteplatz, Berlin, GermanyDepartment of Immunology, Max Planck Institute for Infection Biology, Chariteplatz, Berlin, GermanyMicroscopy Core Facility, Max Planck Institute for Infection Biology, Chariteplatz, Berlin, GermanyMicroscopy Core Facility, Max Planck Institute for Infection Biology, Chariteplatz, Berlin, GermanyDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyDepartment of Pneumology, Clinic, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDivision of Clinical Infectious Diseases, Research Center Borstel, Borstel, GermanyDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, FinlandDepartment of Immunology, Max Planck Institute for Infection Biology, Chariteplatz, Berlin, GermanyABSTRACTActivin A strongly influences immune responses; yet, few studies have examined its role in infectious diseases. We measured serum activin A levels in two independent tuberculosis (TB) patient cohorts and in patients with pneumonia and sarcoidosis. Serum activin A levels were increased in TB patients compared to healthy controls, including those with positive tuberculin skin tests, and paralleled severity of disease, assessed by X-ray scores. In pneumonia patients, serum activin A levels were also raised, but in sarcoidosis patients, levels were lower. To determine whether blockade of the activin A signaling axis could play a functional role in TB, we harnessed a soluble activin type IIB receptor fused to human IgG1 Fc, ActRIIB-Fc, as a ligand trap in a murine TB model. The administration of ActRIIB-Fc to Mycobacterium tuberculosis-infected mice resulted in decreased bacterial loads and increased numbers of CD4 effector T cells and tissue-resident memory T cells in the lung. Increased frequencies of tissue-resident memory T cells corresponded with downregulated T-bet expression in lung CD4 and CD8 T cells. Altogether, the results suggest a disease-exacerbating role of ActRIIB signaling pathways. Serum activin A may be useful as a biomarker for diagnostic triage of active TB or monitoring of anti-tuberculosis therapy.IMPORTANCETuberculosis remains the leading cause of death by a bacterial pathogen. The etiologic agent of tuberculosis, Mycobacterium tuberculosis, can remain dormant in the infected host for years before causing disease. Significant effort has been made to identify biomarkers that can discriminate between latently infected and actively diseased individuals. We found that serum levels of the cytokine activin A were associated with increased lung pathology and could discriminate between active tuberculosis and tuberculin skin-test-positive healthy controls. Activin A signals through the ActRIIB receptor, which can be blocked by administration of the ligand trap ActRIIB-Fc, a soluble activin type IIB receptor fused to human IgG1 Fc. In a murine model of tuberculosis, we found that ActRIIB-Fc treatment reduced mycobacterial loads. Strikingly, ActRIIB-Fc treatment significantly increased the number of tissue-resident memory T cells. These results suggest a role for ActRIIB signaling pathways in host responses to Mycobacterium tuberculosis and activin A as a biomarker of ongoing disease.https://journals.asm.org/doi/10.1128/mbio.03408-23activin AActRIIBtuberculosislatent TB infectionpneumoniasarcoidosis
spellingShingle Natalie E. Nieuwenhuizen
Geraldine Nouailles
Jayne S. Sutherland
Joanna Zyla
Arja H. Pasternack
Jan Heyckendorf
Björn C. Frye
Kerstin Höhne
Ulrike Zedler
Silke Bandermann
Ulrike Abu Abed
Volker Brinkmann
Birgitt Gutbier
Martin Witzenrath
Norbert Suttorp
Gernot Zissel
Christoph Lange
Olli Ritvos
Stefan H. E. Kaufmann
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection
mBio
activin A
ActRIIB
tuberculosis
latent TB infection
pneumonia
sarcoidosis
title Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection
title_full Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection
title_fullStr Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection
title_full_unstemmed Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection
title_short Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection
title_sort activin a levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to m tuberculosis infection
topic activin A
ActRIIB
tuberculosis
latent TB infection
pneumonia
sarcoidosis
url https://journals.asm.org/doi/10.1128/mbio.03408-23
work_keys_str_mv AT natalieenieuwenhuizen activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT geraldinenouailles activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT jaynessutherland activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT joannazyla activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT arjahpasternack activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT janheyckendorf activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT bjorncfrye activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT kerstinhohne activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT ulrikezedler activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT silkebandermann activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT ulrikeabuabed activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT volkerbrinkmann activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT birgittgutbier activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT martinwitzenrath activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT norbertsuttorp activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT gernotzissel activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT christophlange activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT olliritvos activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection
AT stefanhekaufmann activinalevelsareraisedduringhumantuberculosisandblockadeoftheactivinsignalingaxisinfluencesmurineresponsestomtuberculosisinfection